This research aims to assess the bioactive properties of the modified borate glasses containing extremely low concentrations (≤5 mol.%) from chromium sulfate (Cr2(SO4)3). The glasses in the system xCr2(SO4)3.(60–x)B2O3.15CaO.15Na2O.10P2O5, where x = 0, 1, 2, and 5 mol.% were prepared by the melt quenching technique. All glass samples have been treated thermally at 600 °C for 6 h. Fourier Transform Infrared (FTIR) spectroscopy, Scanning Electron Microscopy (SEM), and X-ray Diffraction (XRD) measurements were carried out to differentiate between the structural changes before and after soaking in the simulated body fluid (SBF) at about 37 °C for 1, 2, and 3 weeks. Glass-ceramic samples have showed sharper peaks that are identified using X-ray diffraction data. These crystalline phases are indexed to crystalline calcium borate (Ca2B2O3) and calcium phosphate (Ca3(PO4)2). In vitro tests, FTIR spectra revealed two small bands in the 560-610 cm−1 range which might be assigned to the formation of a hydroxyapatite layer (HA). The formation of HA was also confirmed by XRD results, particularly after immersion in SBF for 21 days. The study suggests that the presently studied glasses containing Cr2(SO4)3 can possess good bioactivity which might be considered to be suitable for some bio and medical applications.